Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

4759-48-2

Isotretinoin

4759-48-2
142796-22-3

Isosilybin B

142796-22-3
142796-21-2

Isosilybin A

142796-21-2
102190-55-6

28-Oxo Ivermectin B1a

102190-55-6
92339-11-2

Iodixanol

92339-11-2
71827-03-7

Ivermectin B1A

71827-03-7
212201-70-2

Ipfencarbazone

212201-70-2
6870-67-3

Jacobine

6870-67-3
16846-24-5

Josamycin

16846-24-5
22071-15-4

Ketoprofene

22071-15-4
492-27-3

Kynurenic acid

492-27-3
25389-94-0

Kanamycin sulfate

25389-94-0
1392-21-8

Leucomycin Hydrate

1392-21-8
1867-66-9

Ketamine HCl

1867-66-9
2922-83-0

L-Kynurenine H2O

2922-83-0
520-18-3

Kaempferol Hydrate

520-18-3
64013-70-3

Kanamycin A disulfate salt

64013-70-3
74103-06-3

Ketorolac

74103-06-3
4680-37-9

3-Keto Fusidic Acid

4680-37-9
34580-14-8

Ketotifen Fumarate

34580-14-8